TelyRx Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	2.99	3.31	0.23
Cash & Short-Term Investments	2.99	3.31	0.23
Cash Growth	-9.84%	1334.63%	-
Receivables	0.46	0.38	0
Inventory	1.35	0.46	0.06
Prepaid Expenses	0.3	0.17	0.03
Other Current Assets	0.46	0.44	10.14
Total Current Assets	5.56	4.77	10.47
Property, Plant & Equipment	3.28	2.54	1.15
Other Intangible Assets	1.04	0.64	0.29
Total Assets	9.88	7.95	11.91
Accounts Payable	2.66	0.94	0.11
Accrued Expenses	3.77	0.5	1.01
Short-Term Debt	-	-	0.06
Current Portion of Long-Term Debt	9.17	-	-
Current Portion of Leases	0.17	0.09	0.06
Current Income Taxes Payable	0.02	-	-
Current Unearned Revenue	0.04	0.02	-
Other Current Liabilities	-	-	5.73
Total Current Liabilities	15.82	1.55	6.97
Long-Term Debt	-	7.21	5.5
Long-Term Leases	2.53	2.23	1.07
Total Liabilities	18.35	10.99	13.54
Common Stock	15.91	15.92	3.84
Retained Earnings	-24.39	-18.96	-5.48
Shareholders' Equity	-8.47	-3.05	-1.64
Total Liabilities & Equity	9.88	7.95	11.91
Total Debt	11.87	9.54	6.69
Net Cash (Debt)	-8.88	-6.22	-6.46
Net Cash Per Share	-0.83	-0.82	-
Filing Date Shares Outstanding	10.69	10.69	-
Total Common Shares Outstanding	10.69	10.69	-
Working Capital	-10.26	3.22	3.5
Book Value Per Share	-0.79	-0.28	-
Tangible Book Value	-9.51	-3.69	-1.93
Tangible Book Value Per Share	-0.89	-0.34	-
Machinery	0.31	0.06	-
Leasehold Improvements	0.52	0.18	0.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.